Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse

This publication has 75 references indexed in Scilit:

• The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study
  Published by Elsevier ,2003
• Ondansetron. A double blind placebo controlled study in acute schizophrenia
  Schizophrenia Research, 1992
• 5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala
  Neuron, 1992
• Antagonism of Low Dose Amphetamine Disruption of Latent Inhibition in Rats By Haloperidol, and By the 5Ht-3 Antagonist, Ondansetron
  Journal of Psychopharmacology, 1992
• Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics
  Trends in Pharmacological Sciences, 1991
• Prevention of Postoperative Nausea and Vomiting Using Ondansetron, a New, Selective, 5-HT3 Receptor Antagonist
  Anesthesia & Analgesia, 1991
• The psychopharmacology of 5-HT3 receptors
  Pharmacology & Therapeutics, 1990
• Cellular and Molecular Mechanisms of Drug Dependence
  Science, 1988
• Antagonism of morphine tolerance and dependece by metoclopramide
  Life Sciences, 1987
• The action of methylated derivatives of 5-hydroxytryptamine at ganglionic receptors
  Neuropharmacology, 1980